The most commonly reported adverse events in the Phase 2 trial were gastrointestinal in nature, including nausea, vomiting, and diarrhoea consistent with the GLP-1 receptor agonist class
Depending on the individual and the particular prescription they are taking, the answer to this question may differ
This strategic move reinforces Novo Nordisks dedication to pioneering innovative therapies for conditions such as obesity, diabetes, and cardiovascular diseases.
Notably, animal models have demonstrated that transferring dysbiotic microbiota from CFS/ME patients to germ-free mice can induce fatigue-like behaviors, supporting a causal role for the microbiome in disease pathogenesis (Bansal et al., 2025)
Tegaserod Tegaserod has been shown to increase gastric emptying
Verify at checkout that your specific tier bundles consultation, medication, and shipping into the stated monthly price without add-ons